| Primary |
| Anaemia |
50.0% |
| Coagulopathy |
50.0% |
|
| Respiratory Distress |
25.0% |
| Transfusion Reaction |
25.0% |
| Transfusion-related Acute Lung Injury |
25.0% |
| Vomiting |
25.0% |
|
| Secondary |
| Retroperitoneal Haemorrhage |
21.4% |
| Anaesthesia |
14.3% |
| Antiplatelet Therapy |
14.3% |
| Product Used For Unknown Indication |
10.7% |
| Anticoagulant Therapy |
7.1% |
| Coronary Artery Bypass |
7.1% |
| Mitral Valve Replacement |
7.1% |
| Acquired Haemophilia |
3.6% |
| Aortic Valve Replacement |
3.6% |
| Factor X Deficiency |
3.6% |
| Mitral Valve Repair |
3.6% |
| Tricuspid Valve Repair |
3.6% |
|
| Death |
16.7% |
| Fear |
16.7% |
| Myocardial Ischaemia |
16.7% |
| Pulmonary Embolism |
16.7% |
| Renal Failure |
16.7% |
| Thrombosis In Device |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
51.4% |
| Drug Use For Unknown Indication |
11.3% |
| Adverse Event |
5.6% |
| Prophylaxis |
4.1% |
| Pain |
4.0% |
| Plasma Cell Myeloma |
3.0% |
| Multiple Myeloma |
2.8% |
| Coronary Artery Bypass |
2.6% |
| Anaemia |
2.2% |
| Premedication |
1.9% |
| B-cell Lymphoma |
1.6% |
| Hypertension |
1.5% |
| Vitamin Supplementation |
1.3% |
| Blood Pressure |
1.1% |
| Anemia |
1.0% |
| Catheterisation Cardiac |
1.0% |
| Supplementation Therapy |
1.0% |
| Fever |
0.9% |
| Hypoglycaemia |
0.9% |
| Hypomagnesemia |
0.9% |
|
| Pain |
9.1% |
| Unevaluable Event |
9.1% |
| Renal Failure Acute |
8.0% |
| Fear |
6.8% |
| Plasma Cell Myeloma |
6.8% |
| Renal Injury |
6.8% |
| Ileus |
5.7% |
| Injury |
4.5% |
| Myelodysplastic Syndrome |
4.5% |
| Myocardial Infarction |
4.5% |
| Sepsis |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Anhedonia |
3.4% |
| Colon Cancer Stage I |
3.4% |
| Hepatic Failure |
3.4% |
| Neutropenia |
3.4% |
| Renal Failure |
3.4% |
| Renal Failure Chronic |
3.4% |
| Lethargy |
2.3% |
| Malignant Melanoma |
2.3% |
|
